What goods or services do you intend to supply? In which countries will customers in your target market reside? How will you reach your target audience? Do you need to exclude potential audiences?...
Target market
What goods or services do you intend to supply?
In which countries will customers in your target market reside?
How will you reach your target audience?
Do you need to exclude potential audiences? (e.g. in countries with which you do not wish to do business).
What legal/regulatory provisions affect your trading/advertising in your target markets?
What risks do you run in non-targeted markets? (e.g. if exclusion methods do not work).
How much will advertising cost?
Do you have the necessary distribution channels to deliver goods to your customers?
How will your target market wish to pay?
Revenue stream
What are your main revenue streams?
Sale of goods?
Sale of advertising?
Commission?
Other?
Data protection
Will you be acquiring personal data?
When and where will you obtain it?
What do you want to do with the data?
What about in three or five years time?
Do you have the necessary consents or registrations?
Do you intend to transfer personal data overseas?
Will personal data be accessible via your web site?
Do you have the necessary consents?
Is any of the data which you are collecting "sensitive"? (See our guide on )
Domain name
Have you decided on your domain name?
Is it short? E.g. "books.com" and not "buyyourbooksonline.com"
Is it easy to remember/obvious?
Have you checked to see if anyone else has registered the same or a similar name in the relevant domain name registries?
Have you undertaken a trade mark search in your chosen target markets?
Have you registered or applied for registration of a trade mark?
Tax and regulation
Will your web site/server:
Expose you to tax in other jurisdictions?
Require you to seek authorisation from regulators in other jurisdictions?
Saudi Arabia is spearheading the operation of mass action frameworks in the Middle East, with a regulatory system that gives shareholders scope to raise securities claims against publicly listed companies and for those claims to then be merged and considered jointly.
A European patent for a drug used in the treatment of high cholesterol has become the first to be revoked following full trial proceedings before the Unified Patent Court (UPC).
Many businesses in South Africa will have to publicise what individual directors earn, while others will fall subject to the country’s takeover rules for the first time, under a raft of changes made to company law.
We use cookies that are essential for our site to work. To improve our site, we would like to use additional cookies to help us understand how visitors use it, measure traffic to our site from social media platforms and to personalise your experience. Some of the cookies that we use are provided by third parties. To accept all cookies click ‘accept all’. To reject all optional cookies click ‘reject all’. To choose which optional cookies to allow click ‘cookie settings’. This tool uses a cookie to remember your choices.
Please visit our cookie policy for more information.
We are processing your request. \n Thank you for your patience.An error occurred. This could be due to inactivity on the page - please try again.